Anti-VEGF Agents Tied to Improved Visual Acuity in Diabetic Macular Edema (FREE)

By Kelly Young Edited by Susan Sadoughi, MD Aflibercept (Eylea), bevacizumab (Avastin), and ranibizumab (Lucentis) all lead to improved vision in patients with diabetic macular edema, although aflibercept may be most effective for those with the worst baseline vision, a New England …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news